Science Changing Life

Science Changing Life

By Science Changing LifeScience
Download on the App Store

Science Changing Life episodes

  • Episode 38 – Danielle Grotjahn: What mitochondria tell us about disease, stress and cell death
    Are the mitochondria truly the powerhouses of the cell? In this episode, assistant professor Danielle Grotjahn shares why she thinks “the stress sensors of the cell” may be a more appropriate name for this cellular organelle–and more. Dr. Grotjahn works in the Department of Integrative Structural and Computational Biology at Scripps Research, where her lab is answering how mitochondrial networks change shape in response to genetic, pharmacological or environmental stress. Listen as we talk about the links between mitochondrial dysfunction and disease, cell death, and the cutting-edge imaging technologies that are enabling Grotjahn and her team to peer into the mysteries of the mitochondria.
    Show notes:
    Episode transcript: https://www.scripps.edu/_files/images/2023_images/danielle-grotjahn-transcript.pdf
    Grotjahn lab website
    https://grotjahnlab.org/
    Twitter
    @nani_grotjahn
    Scripps Research Magazine
    https://magazine.scripps.edu/
    34 min
  • Episode 37 – Stuti Jaiswal: Improving sleep health with wearable devices
    Dr. Stuti Jaiswal is an assistant professor of molecular medicine at Scripps Research and an internist at Scripps Clinic. Listen in as we discuss the health issues associated with insufficient sleep, the best time to go to bed and what the latest wearables can tell us about our sleep patterns.
    Show notes:
    Episode transcript: https://www.scripps.edu/_files/images/2023_images/stuti-jaiswal-transcript.pdf
    REFRESH sleep study at Scripps Research
    https://refresh.scripps.edu/
    The Digital Trials Center current research
    https://digitaltrials.scripps.edu/about/
    Scripps Research Magazine
    https://magazine.scripps.edu/
    34 min
  • Episode 36 – Evert Njomen: Hacking our cellular recycling system to prevent the next deadly pathogen
    Dr. Evert Njomen is a postdoctoral researcher in the lab of Professor Ben Cravatt, based in the Department of Chemistry. Listen as we talk about the autophagy process to cleanse cells, new ways of dealing with antibiotic resistance and cooking with homegrown herbs.
    Show notes:
    Episode transcript: https://www.scripps.edu/_files/images/2022_images/podcast-images/Evert-Njomen-transcript.pdf
    Evert awarded prestigious fellowship from the Howard Hughes Medical Institute
    https://www.scripps.edu/news-and-events/press-room/2021/20210304-njomen-howard-hughes-medical-institute-fellowship.html
    Cravatt lab website
    https://www.scripps.edu/cravatt/index.html
    Tweet @EvertNjomen
    Explore the Scripps Research Magazine
    https://magazine.scripps.edu/
    Subscribe to receive our monthly e-newsletter
    https://signup.e2ma.net/signup/1879047/1890109/
    @scrippsresearch on Twitter
    19 min
  • Episode 35 – Andrew Su: How artificial and community intelligence are shaping medicine
    Professor Andrew Su is based in the Department of Integrative Structural and Computational Biology, where his lab develops digital tools to draw conclusions from the vast streams of medical data generated each day. Listen to us discuss gaming as a way of being a scientist, the replacement of doctors with machine-learning and your Netflix watching history.
    Show notes:
    Episode transcript: https://www.scripps.edu/_files/images/2022_images/podcast-images/Andrew-Su-transcript.pdf
    Andrew’s TEDx talk: Building the knowledgebase of biology using citizen science
    https://www.youtube.com/watch?v=hT_pj1cB0Q8
    Su lab website
    https://sulab.org/
    Tweet: @andrewsu
    Citizen science initiatives:
    https://www.zooniverse.org/
    https://fold.it/
    https://stallcatchers.com/main
    Explore the Scripps Research Magazine
    https://magazine.scripps.edu/
    Subscribe to receive our monthly e-newsletter
    https://signup.e2ma.net/signup/1879047/1890109/
    @scrippsresearch on Twitter
    27 min
  • Episode 34 – Travis Young: Finding a cure for cancer with novel immunotherapies
    Dr. Travis Young is the Vice President of Biologics at Calibr, the drug discovery and development division of Scripps Research. Travis and the team have created a new type of immunotherapy called “switchable” chimeric antigen receptor (CAR) T-cell therapy, which is already delivering precise and powerful therapies to patients with the most difficult to treat cancers. Listen as we talk about reengineering an individual’s immune T cells, promising clinical trials in leukemia and lymphoma patients, and using similar approaches to treat autoimmune diseases.
    Show notes:
    Episode transcript: https://www.scripps.edu/_files/images/2022_images/podcast-images/Travis-Young-transcript.pdf
    Travis and his colleagues discuss ongoing therapies being developed at Calibr during the Front Row lecture series
    https://www.youtube.com/watch?v=WRzQniqUlHo&t=2625s
    Preliminary results of switchable CAR-T cells in lymphoma patients
    https://www.scripps.edu/news-and-events/press-room/2021/20211208-calibr-announces-clinical-data-car-t-cells.html
    Tweet: @CARTCellTherapy
    Explore the Scripps Research Magazine
    https://magazine.scripps.edu/
    Subscribe to receive our monthly e-newsletter
    https://signup.e2ma.net/signup/1879047/1890109/
    @scrippsresearch on Twitter
    30 min
  • Episode 33 – Frederick Barrett: Psychoactive compounds to treat depression, addiction & inflammation
    Part three of our mini-series centered on brain health. Professor Frederick Barrett is based in the Department of Psychological & Brain Sciences at Johns Hopkins School of Medicine and Associate Director at the Center for Psychedelic and Consciousness Research. Fred and his colleagues investigate the therapeutic effects of psychoactive substances in intractable patient populations, including those with depression, opioid use disorder and cognitive impairments. Listen as we talk about the different types of hallucinogenic mushrooms, whether psychedelics could one day treat neurodegeneration and the remedial value of a bad “trip.”
    Show notes:
    Episode transcript: https://www.scripps.edu/_files/images/2022_images/podcast-images/Frederick-Barrett-transcript.pdf
    Fred’s TEDMED talk: The neuroscience of psychedelic drugs, music and nostalgia
    https://www.ted.com/talks/frederick_streeter_barrett_the_neuroscience_of_psychedelic_drugs_music_and_nostalgia?language=en
    Center for Psychedelics and Consciousness Research
    https://hopkinspsychedelic.org/barrett
    Tweet: @FredBarrettPhD
    Explore the Scripps Research Magazine
    https://magazine.scripps.edu/
    Subscribe to receive our monthly e-newsletter
    https://signup.e2ma.net/signup/1879047/1890109/
    @scrippsresearch on Twitter
    23 min
  • Episode 32 – Ryan Shenvi: Ethnomedicine to improve learning, memory and mental health
    The second part of our three-part mini-series on brain health. Professor Ryan Shenvi is based in the Department of Chemistry at Scripps Research, where his lab reconstructs useful molecules typically found in remote corners of the world. Listen as we talk about traditional remedies of indigenous cultures, formulating medicines from industrial waste and Charles Dickens’ drinking habits.
    Show notes:
    Episode transcript: https://www.scripps.edu/_files/images/2022_images/podcast-images/Ryan-Shenvi-transcript.pdf
    Shenvi finds a quick way to synthesize novel neuroactive compounds found in rainforest tree
    https://www.scripps.edu/news-and-events/press-room/2022/20220317-shenvi-neuroactive-compounds-in-rainforest-tree.html
    Q&A with Ryan
    https://magazine.scripps.edu/profiles/2022/online-exclusive/channeling-ethnomedicine-to-address-mental-health/
    Shenvi lab website
    https://www.shenvilab.org/
    Tweet: @Shenvi_Lab
    Explore the Scripps Research Magazine
    https://magazine.scripps.edu/
    Subscribe to receive our monthly e-newsletter
    https://signup.e2ma.net/signup/1879047/1890109/
    @scrippsresearch on Twitter
    27 min
  • Episode 31 – Sandra Encalada: Linking traffic jams in the brain to neurodegenerative disease
    We kick off the Summer 2022 podcast season with the first of a three-part mini-series dedicated to brain health. Professor Sandra Encalada is based in the Department of Molecular Medicine at Scripps Research, where her lab investigates the transport of cargo within brain cells and its role in health and disease. Listen as we talk about new therapeutic agents to stop and reverse neurodegeneration, environmental neurotoxins and when to listen to your gut feeling.
    Show notes:
    Episode transcript: https://www.scripps.edu/_files/images/2022_images/podcast-images/Sandra-Encalada-transcript.pdf
    Encalada illuminates how brain cells die in prion diseases
    https://www.scripps.edu/news-and-events/press-room/2021/20211222-encalada-brain-cells-prion-diseases.html
    Encalada lab website
    https://www.encalada.scripps.edu/
    Tweet: @EncaladaLab
    Explore the Scripps Research Magazine
    https://magazine.scripps.edu/
    Subscribe to receive our monthly e-newsletter
    https://signup.e2ma.net/signup/1879047/1890109/
    31 min
  • Episode 30 – The biochemistry of aging: Scripps Research Magazine
    The fifth and final episode in our healthy aging series. We discover what happens inside the cell with age and how new chemical tools are leading us towards ways of repairing the damage and preserving our youth.
    This article is taken from the Summer 2021 of our award-winning Scripps Research Magazine.
    Show notes:
    Explore the Scripps Research Magazine
    https://magazine.scripps.edu/
    7 min

About Science Changing Life

From the publisher's feed

The award-winning Science Changing Life podcast offers an inside look into how Scripps Research scientists are solving the most pressing mysteries in human health and disease. Join hosts Lauren Fish and Melissa Suran, PhD, as they speak with world-class scientists at the forefronts of immunology, infectious disease, artificial intelligence, personalized medicine, neuroscience and much more.